PTEN Stock: Patterson-UTI Energy Inc. (NASDAQ:PTEN) Is ... Mar 06, 2020 · 12 out of 25 analysts covering the stock have rated it a Buy, while 6 have maintained a Hold recommendation on Patterson-UTI Energy Inc.. 5 analysts has assigned a Sell rating on the PTEN stock. The 12-month mean consensus price target for the company’s shares has been set at $8.51. Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Given Average ... Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN) have been assigned a consensus recommendation of “Hold” from the twenty-four research firms that are currently covering the stock, Marketbeat.com reports. Eight equities research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have issued a buy rating on the company. […] Patterson-UTI Energy (PTEN) Stock closed with change of -5 ...
Today's Strong Sells | The Motley Fool - Stock Research
Jan 03, 2020 · Patterson-UTI Energy, Inc. (NASDAQ:PTEN) shareholders should be happy to see the share price up 27% in the last quarter.But that is small recompense for the exasperating returns over three years PTEN - Research and Analysis for PATTERSON-UTI ENERGY, INC ... In-depth view of key statistics and finances for PATTERSON-UTI ENERGY, INC. (PTEN) on MSN Money. PTEN Hamartoma Tumor Syndrome | Children's Hospital of ...
PTEN Stock News - Fidelity
Stock Target Advisor runs millions of automatic calculations on over 75,000 stocks in American, Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. FET Stock Price, Forecast & News (Forum Energy Technologies)
Patterson-UTI Energy, Inc. - Zacks Investment Research
Jul 28, 2015 · Patterson-UTI Energy (PTEN) Stock Rising on Mixed Analyst Note Patterson-UTI Energy (PTEN) price target was lowered to $20 from $24 at Deutsche … PTEN Hamartoma Tumor Syndrome - NORD (National ... The PTEN hamartoma tumor syndrome (PHTS) is a spectrum of disorders caused by mutations of the PTEN tumor suppressor gene in egg or sperm cells (germline). These disorders are characterized by multiple hamartomas that can affect various areas of the body. Patterson-UTI Energy Inc, PTEN:NSQ summary - FT.com Latest Patterson-UTI Energy Inc (PTEN:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Curtis Huff Is The Lead Director of Patterson-UTI Energy ... Mar 12, 2020 · Whilst it may not be a huge deal, we thought it was good to see that the Patterson-UTI Energy, Inc. (NASDAQ:PTEN) Lead Director, Curtis Huff, recently bought US$94k worth of …
PTEN stock rating and analysis - Patterson-UTI Energy : a summary of key financial strength and profitability metrics. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it
In-depth view of key statistics and finances for PATTERSON-UTI ENERGY, INC. (PTEN) on MSN Money. PTEN Hamartoma Tumor Syndrome | Children's Hospital of ... PTEN hamartoma tumor syndrome (PHTS) includes a group of clinical disorders caused by alterations in the PTEN gene.In the past, these clinical disorders were called by one of several names, including: Cowden syndrome (CS) Bannayan-Riley-Ruvalcaba syndrome (BRRS)
PTEN Split History Patterson-UTI Energy (PTEN) has 3 splits in our PTEN split history database. The first split for PTEN took place on July 28, 1997. This was a 2 for 1 split, meaning for each share of PTEN owned pre-split, the shareholder now owned 2 shares.